Host antisecretory targets are a promising treatment option for easing the symptoms of diarrheal disease and addressing shortcomings of existing therapies. This poster presentation from the American Society of Tropical Medicine and Hygiene 2016 Annual Meeting summarizes the results of tests comparing several clinical-stage drug candidates that have the potential to treat acute secretory diarrhea.